Project Grant H8E38852

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

This federal Project Grant award of $2,500,000 from the U.S. Department of Health and Human Services under the Congressional Directives program (CFDA 93.493) will support the County of San Diego's Public Health Laboratory (PHL). The funds will be used to improve the PHL's testing capabilities through the procurement of updated instrumentation and equipment for the new PHL facility, which is projected to be completed by April 2025. This includes movable laboratory equipment, ancillary items...

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

DPX Technologies LLC received a $254,536 Project Grant award from the National Science Foundation to develop high-throughput COVID-19 testing under the SBIR PHASE I program. The award, provided by NSF's Directorate for Engineering between April 1, 2021 and September 30, 2021, aims to foster innovation in engineering research and development under the Engineering (47.041) federal grant program. Specifically, DPX Technologies will leverage the funding to create products and services focused on...

Federal Project Grant Award Summary Esper Biosciences Inc. received a $380,334 Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) on September 30, 2025, to develop a rapid point-of-care nucleic acid test for Hepatitis C using nanosensor technology. The project, based in Ithaca, New York, carries a performance period of one year, concluding September 29, 2026. This funding supports the development of an...

Federal Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) effective September 30, 2025, with a completion date of March 31, 2026. The award supports the development of an ultrasensitive urine tuberculosis antigen rapid detection test designed to improve the diagnosis of active tuberculosis. This innovation addresses a critical public health need...

Summary SKM Instruments, LLC received a $572,722 Project Grant from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) awarded on September 30, 2025, with performance completion targeted for May 31, 2026. The project focuses on developing an ultra-rapid optical platform for antimicrobial susceptibility testing (AST) of pulmonary non-tuberculous mycobacterial (NTM) infections. This technology platform represents an innovative...

Federal Grant Award Summary Nanohmics Inc. received a $1,047,807 Project Grant from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) on September 30, 2025, to develop lateral flow-electrochemiluminescent (LF-ECL) test strips and a portable reader system for ultrasensitive foodborne pathogen detection. The project will be performed in Austin, Texas, with an expected completion date of September 29, 2027. This two-year initiative...

Cellbae Inc. received a $174,992 Small Business Innovation Research Project Grant from the US Department of Agriculture National Institute of Food and Agriculture to develop rapid test kits for the detection of Escherichia coli O157:H7 and Salmonella enterica. The goal of the six-month project beginning July 1, 2023 is to verify the sensitivity and specificity of Cellbae's rapid test kit platform, which uses enzymatic amplification to increase detection sensitivity over conventional methods....